Anna McCollister-Slipp is the co-founder of Galileo Analytics, a visual data exploration and advanced data analytics company focused on democratizing access to and understanding of complex health data.
Anna’s passion for improving health care research through innovation in health data analytics is rooted in her personal experiences living with type 1 diabetes. In her professional and personal activities, Anna seeks to build platforms for better understanding of and engagement with the needs of patients. She speaks frequently about the need for innovation in medical device data and technology, promoting data standards, device interoperability and user platforms aimed at empowering patients to better manage their health.
In addition, Anna is a vocal advocate for improving methods for comparative effectiveness research and the development of more refined outcomes measures to better guide care and assess treatments. She serves on the National Quality Forum’s Endocrine Standing Committee, charged with evaluating proposed quality measures for use with CMS’ performance and incentive programs. She was a member of the FDA/ONC/FCC HIT Policy Committee’s FDASIA Working Group, which advised the agencies on creating a regulatory pathway that will help protect patients, while enabling and promoting innovation in HIT systems, mobile applications and medical device interoperability. She is a member of the FDA’s advisory committee on General Hospital and Personal Use Medical Devices, and serves on the steering committee for FDA’s MDEpiNet, which is working to establish a system for improving medical device product safety surveillance and comparative effectiveness research.
Anna’s work as an entrepreneur, innovator and advocate for medical device interoperability and improved outcomes measures has been profiled in publications, such as by HealthLeaders Media, MobiHealth News, Medscape and Search Health IT. She was named by XX In Health as a “Woman to Watch” at Health Datapalooza 2013, and as co-founder of Galileo Analytics, was one of a select group of innovators invited to participate in “The Hive” at TEDMED 2013.
Simon is a knowledge engineer with 30 years experience in market research, data analytics and business intelligence within the pharmaceutical, biotechnology and medical device industries.
Paul is the Chief Technology Architect at Galileo. He has more than 30 years experience in data systems design and management. His specific expertise is focused on creating data system architectures.
Gilgamesh is the lead programmer at Galileo Analtyics, playing a key role in each and every aspect of the design and implementation of the Galileo Cosmos™ system.